Phenylacetaldehyde glyceryl acetal
Common Name: |
Phenylacetaldehyde glyceryl acetal |
IUPAC Name: |
(2-benzyl-1,3-dioxolan-4-yl)methanol |
Molecular Formula: |
C6H8N2 |
SMILES: |
C1C(OC(O1)CC2=CC=CC=C2)CO |
Inchi: |
1S/C11H14O3/c12-7-10-8-13-11(14-10)6-9-4-2-1-3-5-9/h1-5,10-12H,6-8H2 |
Inchi Key: |
ZPENOSKWEKGDCX-UHFFFAOYSA-N |
Cas No: |
5694-72-4 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
108.14 |
Mass (g/mol) |
194.094 |
Molar Refractivity |
31.96 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
0 |
Rings |
2 |
TPSA |
25.78 |
Hetero Atoms |
3 |
Heavy Atoms |
8 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
302.00 to 304.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.00016 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.33 |
LogP |
0.963 |
iLOGP |
1.57 |
XLOGP3 |
0.54 |
WLOGP |
1.09 |
MLOGP |
-0.14 |
ESOL Log S |
-1.41 |
ESOL Solubility (mg/ml) |
4.25 |
ESOL Solubility (mol/l) |
0.039 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-0.65 |
Ali Solubility (mg/ml) |
24 |
Ali Solubility (mol/l) |
0.22 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.36 |
Silicos-IT Solubility (mg/ml) |
0.47 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.58 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.318 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
1 |
Acute Oral Toxicity |
1.597 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Danger |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |